Increased lipid peroxidation in the brains of aceruloplasminemia patients

Journal of the Neurological Sciences

Volumn 175, Issue 2, 2000, Pages 91-95

  Yoshida, Kunihiro ^a,b   Kaneko, Kazuma ^a   Miyajima, Hiroaki ^c   Tokuda, Takahiko ^a   Nakamura, Akinori ^a   Kato, Masahiro ^a   Ikeda, Shu Ichi ^a,b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aceruloplasminemia; Ceruloplasmin; Lipid peroxidation; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; CERULOPLASMIN; IRON; MALONALDEHYDE; OXYGEN RADICAL; POLYUNSATURATED FATTY ACID; PROTEIN ANTIBODY;

ACERULOPLASMINEMIA; ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CASE REPORT; CELL DEATH; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; FRONTAL CORTEX; GENE MUTATION; GENETIC DISORDER; GLIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; METABOLIC DISORDER; OXIDATIVE STRESS; PRIORITY JOURNAL; PUTAMEN;

AGED; AGED, 80 AND OVER; ALDEHYDES; BRAIN; CERULOPLASMIN; HEMOSIDEROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED;

EID: 0034656236     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00295-1     Document Type: Article

References (18)

1. Harris Z.L., Morita H., Gitlin J.D. The biology of human ceruloplasmin. Messerschmidt A. Multi-copper oxidases. 1997;285-305 World Scientific, Singapore.
2. Gitlin J.D. Aceruloplasminemia. Pediatr. Res. 44:1998;271-276.
3. Yoshida K. Clinicopathological and molecular genetic features of hereditary ceruloplasmin deficiency (aceruloplasminemia). Sarkar B. Metals and Genetics. 1999;301-311 Plenum Publisher's, New York.
4. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S., Kato M., Yanagisawa N. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann. Neurol. 37:1995;646-656.
5. Kawanami T., Kato T., Daimon M., Tominaga M., Sasaki H., Maeda K., Arai S., Shikama Y., Katagiri T. Hereditary caeruloplasmin deficiency: clinicopathological study of a patient. J. Neurol. Neurosurg. Psychiatry. 61:1996;506-509.
6. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
7. De Silva D.M., Aust S.D. Ferritin and ceruloplasmin in oxidative damage: review and recent findings. Can. J. Physiol. Pharmacol. 71:1993;715-720.
8. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
9. Miyajima H., Takahashi Y., Serizawa M., Kaneko E., Gitlin J.D. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Rad. Biol. Med. 20:1996;757-760.
10. Miyajima H., Takahashi Y., Kamata T., Shimizu H., Sakai N., Gitlin J.D. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann. Neurol. 41:1997;404-407.
11. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128.
12. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T.A., Gitlin J.D. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA. 92:1995;2539-2543.
13. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 37:1987;761-767.
14. Miyajima H., Fujimoto M., Kohno S., Kaneko E., Gitlin J.D. CSF abnormalities in patients with aceruloplasminemia. Neurology. 51:1998;1188-1190.
15. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H., Hiyamuta S., Ikeda S., Shimizu N., Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet. 9:1995;267-272.
16. Uchida K., Itakura K., Kawakishi S., Hiai H., Toyokuni S., Stadtman E.R. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324:1995;241-248.
17. Gutteridge J.M.C., Richmond R., Halliwell B. Oxygen free-radicals and lipid peroxidation: inhibition by the protein caeruloplasmin. FEBS Lett. 112:1980;269-272.
18. Gutteridge J.M.C. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett. 157:1983;37-40.